Edesa Biotech, Inc. (EDSA) vs Metagenomi, Inc. Common Stock (MGX)

A side-by-side comparison of Edesa Biotech, Inc. and Metagenomi, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Edesa Biotech, Inc. logo
EDSA
Edesa Biotech, Inc.
$37M
$3.82HealthcareDelayed quote: Oct 6, 2026, 2:29 PM EDT
Metagenomi, Inc. Common Stock logo
MGX
Metagenomi, Inc. Common Stock
$39M
$1.04HealthcareDelayed quote: Oct 6, 2026, 2:24 PM EDT

Total return — EDSA vs MGX

growth of $100 · dividends reinvested · last 3y
EDSA -22.9% (-8.3%/yr)MGX -89.9% (-53.4%/yr)EDSA compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $10020252026$77$10
EDSA MGX

EDSA vs MGX: by the numbers

  • •MGX is the larger company ($39M vs $37M market cap).
  • •Both run net losses; EDSA's is the smaller (0.00% vs -689.20% net margin).

Metrics side by side

Valuation

MetricEDSAMGX
P/S ratioN/A2.89
P/B ratio92.110.35

Profitability

MetricEDSAMGX
Gross margin0.00%74.29%
Operating margin0.00%-380.85%
Net margin0.00%-689.20%
ROE-160.05%-83.03%
ROIC-166.02%-66.03%

Growth (annualized)

MetricEDSAMGX
Total return CAGR (5Y)-39.88%N/A

Go deeper

Full EDSA analysisFull MGX analysisInteractive comparison tool

Dig into the metrics

Edesa Biotech ROEMetagenomi, Inc. Common Stock ROEEdesa Biotech operating marginMetagenomi, Inc. Common Stock operating marginEdesa Biotech revenue growthMetagenomi, Inc. Common Stock revenue growthEdesa Biotech free cash flowMetagenomi, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.